In addition, patients with ESCC showing higher CXCL10 expression had a better overall survival rate when compared with CXCL10-negative patients [119], while enhanced proliferation and metastatic behavior of melanoma tumor cells could be linked to higher CXCL10 secretion [120]. This evidence concerns the gene CXCL10 and neoplasm.